Concepedia

Author

Neil G. Snowise

GlaxoSmithKline (United Kingdom)ORCID

Also Known As

N G Snowise, N Snowise, N. G. Snowise, N.G. Snowise, Neil G Snowise, Neil G. Snowise, Neil Snowise, Snowise N

28

Publications

345

Citations

10

H-Index

6

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)GlaxoSmithKline (United States)McMaster UniversityKing's College LondonResearch Triangle Park Foundation
NG

About

Neil G. Snowise is an author at GlaxoSmithKline (United Kingdom) specializing in allergy, clinical trials, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

30

2

Allergy

1

1

30

3

Pharmacology

1

1

30

4

Asthma

1

1

30

5

Clinical Trials

1

1

30

Neil G. Snowise

×

10

Publications

316

Citations

10

H-Index

YearCitations

INTREPID: single-<i>versus</i>multiple-inhaler triple therapy for COPD in usual clinical practice

David Halpin, Sally Worsley, Afisi Ismaila,

ERJ Open Research

2021

63

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

Ashley Woodcock, Eugene R. Bleecker, Jan Lötvall,

Respiratory Research

2011

45

Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting

David Halpin, Kieran Rothnie, Victoria Banks,

International Journal of COPD

2022

44

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

Ashley Woodcock, Eric D. Bateman, Jan Lötvall,

Respiratory Research

2011

42

Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial

Richard K. Sterling, Jessica Lim, Lucy Frith,

Respiratory Medicine

2012

30

Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study

Richard Follows, Neil G. Snowise, Shuyen Ho,

Respiratory Research

2013

29

Fluticasone Furoate Nasal Spray is Effective and Well Tolerated for Perennial Allergic Rhinitis in Adolescents and Adults

John Given, Amarjit Cheema, Tilman Dreykluft,

American Journal of Rhinology and Allergy

2010

22

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design

Sally Worsley, Neil G. Snowise, David Halpin,

ERJ Open Research

2019

15

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

Neil G. Snowise, Diane Clements, Shuyen Ho,

Current Medical Research and Opinion

2013

14

General practice partnerships: till death us do part?

Neil G. Snowise

BMJ

1992

12

Page 1